| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.0007 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |